Purchase Order 75N91021P00748
Award Date 8/23/21
Potential Completion Date 8/23/22
Potential Value $190K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Norway
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $994,520 contract is for dietary biomarker development work in support of three NCI-funded studies: the Interactive Diet and Activity Tracking in AARP (IDATA) Study, the Women's Alcohol Study (WAS), and the Golestan Cohort Study (GCS). This award supports Metabolon's specialized metabolomics analysis...
- This is a definitive Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to the Cancer Hospital, Chinese Academy Of Medical Sciences, a non-profit organization based in China. The contract, valued at $206,082.00, is for a "NUTRITION INTERVENTION TRIAL BIOBANK" and has a completion date of September 19, 2027. The contract is not designated as a set-aside. No additional information about subcontractors, larger contract vehicles, or the agency's...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,700 firm fixed price purchase order to Human Metabolome Technologies America, Inc. to provide laboratory and testing services, including an Omega Scan option with no additional cost. The place of performance will be in Bethesda, Maryland. The contract period of performance spans from August 1, 2023 through November 30, 2023. No subcontractors or set aside designations were...
- This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian federal agency, to The Gertner Institute for Epidemiology & Health Policy Research LTD, a non-profit organization located in Israel. The $304,823.00 contract is for services to collect exposure information and covariate data from paper and electronic clinic records from 16 in vitro fertilization (IVF) clinics. The base period of performance is 1 year with 1 option year. The contract does...
- This federal contract award to Labmedtech AS, a for-profit organization based in Latvia, is valued at $84,990.00 and was issued by the National Cancer Institute (NCI) of the U.S. Department of Health and Human Services. The contract requires Labmedtech to perform assays on plasma samples from the Golestan Cohort Study to investigate the role of serum pepsinogen I, pepsinogen II, and TFF3 in predicting the risk of gastric cancer development. The contract is a firm fixed-price purchase order...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
- <p>The National Cancer Institute issued a purchase order to Kobenhavns Universitet valued at $39,999.30 on September 18, 2017, for biomarkers of progression of oral leukoplakia to oral cancer. Performance is in Denmark under firm fixed price terms. The order was completed on September 17, 2018.</p>
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $51,660 firm fixed price delivery order to Olink Proteomics AB of Watertown, Massachusetts. The order is for services to evaluate circulating biomarkers in cancer in support of the Division of Cancer Epidemiology and Genetics. The award has a period of performance through February 4, 2022. No set-aside provisions were applied to this order issued under an unspecified preexisting contract...